TRAW
Financials
- Market Capitalization 10.76 M
- Employee 7
- Founded 1998
- CEO N/A
- Website www.trawspharma.com
- Headquarter Delaware, United States
- FIGI BBG000R338X6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4795 |  XCUR Exicure, Inc. - Common Stock | 1.78 USD | +7.88% | -10.55% | -35.27% | -75.28% | 11.35 M USD | ||
| 4799 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.51 USD | +2.03% | -1.95% | -1.57% | +19.52% | 11.12 M USD | ||
| 4813 |  BCDA BioCardia, Inc. - Common Stock | 0.88 USD | -3.30% | -16.19% | 0.00% | -23.81% | 10.01 M USD | ||
| 4815 |  CVM Cel-Sci Corporation Common Stock | 1.16 USD | -5.69% | -8.66% | +13.73% | -77.48% | 9.85 M USD |
Frequently asked questions about Traws Pharma, Inc. - Common Stock
What is the Traws Pharma, Inc. - Common Stock stock price today?
The current price of Traws Pharma, Inc. - Common Stock (TRAW) is 0.71. Over the past 24 hours, the stock has changed by +4.41%. Follow the TRAW chart for real-time price dynamics.
What is the stock ticker of Traws Pharma, Inc. - Common Stock?
Traws Pharma, Inc. - Common Stock trades under the ticker TRAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Traws Pharma, Inc. - Common Stock stock going up?
TRAW has changed by -2.74% over the last week, -34.86% over the last month, and -54.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Traws Pharma, Inc. - Common Stock net income for the last quarter?
Traws Pharma, Inc. - Common Stock reported net income of -7.11 M for the last quarter. The previous quarter showed -3.96 M, which means net income changed by -79.38%.
How many employees does Traws Pharma, Inc. - Common Stock have?
As of the latest available data, Traws Pharma, Inc. - Common Stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
What is Traws Pharma, Inc. - Common Stock EBITDA?
Traws Pharma, Inc. - Common Stock EBITDA is -6.84 M, and its EBITDA margin is -12.01 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Traws Pharma, Inc. - Common Stock stock?
You can buy Traws Pharma, Inc. - Common Stock (TRAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Traws Pharma, Inc. - Common Stock stock?
Investing in Traws Pharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRAW chart and related analysis on metatrader.com as part of your research.